(Q39147992)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27894373%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

title

Cognitive effects of adjunctive N-acetyl cysteine in psychosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27894373%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27894373%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Ashley I. Bush

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27894373%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

David R Skvarc

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27894373%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Michael Berk

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27894373%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

author name string

S Dodd

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27894373%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

G S Malhi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27894373%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Z X On

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27894373%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

O M Dean

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27894373%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

language of work or name

English

0 references

publication date

29 November 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27894373%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

published in

Psychological Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27894373%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27894373%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27894373%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

page(s)

866-876

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27894373%20AND%20SRC:MED&resulttype=core&format=json

Working memory and depressive symptoms in patients with schizophrenia and substance use disorders.

28 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

N-acetyl cysteine treatment rescues cognitive deficits induced by mitochondrial dysfunction in G72/G30 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Acute Effects of Ketamine on Memory Systems and Psychotic Symptoms in Healthy Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Neurocognition in first-episode schizophrenia: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Cognition as a target in schizophrenia, bipolar disorder and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Inflammatory mediators of cognitive impairment in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Mechanisms of synaptic plasticity and recognition memory in the perirhinal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Differential neurodevelopmental trajectories in patients with early-onset bipolar and schizophrenia disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Cognitive change in the year after a first manic episode: association between clinical outcome and cognitive performance early in the course of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Shared and distinct neurocognitive endophenotypes of schizophrenia and psychotic bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

The neurobiology and treatment of first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

N-acetyl cysteine supplementation prevents impairment of spatial working memory functions in rats following exposure to hypobaric hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Glutamate and dopamine in schizophrenia: an update for the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Extracting spurious messages from noise and risk of schizophrenia-spectrum disorders in a prodromal population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Amelioration of acute sequelae of blast induced mild traumatic brain injury by N-acetyl cysteine: a double-blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Global assessment of functioning. A modified scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

The acute effects of NMDA antagonism: from the rodent to the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Molecular targets for treating cognitive dysfunction in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Working memory as a predictor of negative symptoms and functional outcome in first episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Revising axis V for DSM-IV: a review of measures of social functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Neuropsychological functioning in early-onset first-episode psychosis: comparison of diagnostic subgroups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

The impact of NMDA receptor blockade on human working memory-related prefrontal function and connectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Putative neuroprotective agents in neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Fetal programming of schizophrenia: select mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Effects of N-acetyl cysteine on cognitive function in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

A rating scale for mania: reliability, validity and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Cytokines and cognition--the case for a head-to-toe inflammatory paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Development and reliability of a structured interview guide for the Montgomery Asberg Depression Rating Scale (SIGMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Cognitive impairment in first-episode mania: a systematic review of the evidence in the acute and remission phases of the illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Cognitive enhancing agents in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Specificity of cognitive deficits in bipolar disorder versus schizophrenia. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Effects of N-acetyl-cysteine treatment on glutathione depletion and a short-term spatial memory deficit in 2-cyclohexene-1-one-treated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Thalamic neurochemical abnormalities in individuals with prodromal symptoms of schizophrenia - relationship to auditory event-related potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Meta-analysis of Cognitive Impairment in First-Episode Bipolar Disorder: Comparison With First-Episode Schizophrenia and Healthy Controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

N-acetylcysteine for the treatment of glutathione deficiency and oxidative stress in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Reduced mismatch negativity predates the onset of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

The chemistry and biological activities of N-acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Glutamate receptor function in learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Neuropsychological evidence for abnormal neurodevelopment associated with early-onset psychoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Glutathione: a novel treatment target in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluating pharmacological treatment effects and as intermediate phenotypes for gene discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer's disease: a 1-year, open-label pilot study with an 16-month caregiver extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Glutathione precursor N-acetyl-cysteine modulates EEG synchronization in schizophrenia patients: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Qualitative methods in early-phase drug trials: broadening the scope of data and methods from an RCT of N-acetylcysteine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

The promise of N-acetylcysteine in neuropsychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Towards stage specific treatments: effects of duration of illness on therapeutic response to adjunctive treatment with N-acetyl cysteine in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Clinical Staging in Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Cognitive intervention in early psychosis — preserving abilities versus remediating deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

Executive Function in Patients with Remitted Bipolar Disorder and Schizophrenia and Its Relationship with Functional Outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

7 January 2021

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

7 January 2021

Cognitive functioning in prodromal psychosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

7 January 2021

Reversing brain damage in former NFL players: implications for traumatic brain injury and substance abuse rehabilitation.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

7 January 2021

Impairments of working memory in schizophrenia and bipolar disorder: the effect of history of psychotic symptoms and different aspects of cognitive task demands

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

7 January 2021

Theories of schizophrenia: a genetic-inflammatory-vascular synthesis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

7 January 2021

Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

7 January 2021

Glutamatergic modulation of auditory information processing in the human brain

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

7 January 2021

Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291716002932

7 January 2021

10.1017/S0033291716002932

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27894373%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference